Open Forum Infectious Diseases最新文献

筛选
英文 中文
A Pumpless and Tubeless Microfluidic Device Enables Extended In Vitro Development of Cryptosporidium parvum. 无泵、无管微流体设备可扩展副隐孢子虫的体外培养
IF 3.8 4区 医学
Open Forum Infectious Diseases Pub Date : 2024-10-16 eCollection Date: 2024-11-01 DOI: 10.1093/ofid/ofae625
Samantha Gunasekera, Benjamin Thierry, Edward Cheah, Brendon King, Paul Monis, Jillian M Carr, Abha Chopra, Mark Watson, Mark O'Dea, Una Ryan
{"title":"A Pumpless and Tubeless Microfluidic Device Enables Extended In Vitro Development of <i>Cryptosporidium parvum</i>.","authors":"Samantha Gunasekera, Benjamin Thierry, Edward Cheah, Brendon King, Paul Monis, Jillian M Carr, Abha Chopra, Mark Watson, Mark O'Dea, Una Ryan","doi":"10.1093/ofid/ofae625","DOIUrl":"https://doi.org/10.1093/ofid/ofae625","url":null,"abstract":"<p><strong>Background: </strong>The enteric parasite <i>Cryptosporidium</i> remains a treatment challenge for drinking water utilities globally due to its resistance to chlorine disinfection. However, the lack of an in vitro culture system for <i>Cryptosporidium</i> that is both cost-effective and reliable remains a key bottleneck in <i>Cryptosporidium</i> research.</p><p><strong>Methods: </strong>Here we report that the microfluidic culture of human ileocecal colorectal adenocarcinoma (HCT-8) cells under fluid shear stress enables the extended development of <i>Cryptosporidium parvum</i>. Specifically, the growth of <i>C. parvum</i> in a user-friendly pumpless microfluidic device was assessed using immunofluorescence assays, scanning electron microscopy, and quantitative polymerase chain reaction, which revealed that development continued for 10 days in total.</p><p><strong>Results: </strong>Oocysts produced within the microfluidic device were infective to fresh HCT-8 monolayers; however, these oocysts were only present at low levels.</p><p><strong>Conclusions: </strong>We anticipate that such microfluidic approaches will facilitate a wide range of in vitro studies on <i>Cryptosporidium</i> and may have the potential to be further developed as a routine infectivity assessment tool for the water industry.</p>","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":"11 11","pages":"ofae625"},"PeriodicalIF":3.8,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11542632/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142605724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Altered Spike Immunoglobulin G Fc N-Linked Glycans Are Associated With Hyperinflammatory State in Adult Coronavirus Disease 2019 and Multisystem Inflammatory Syndrome in Children. 尖峰免疫球蛋白 G Fc N 联糖蛋白的改变与成人冠状病毒病 2019 和儿童多系统炎症综合征的高炎症状态有关。
IF 3.8 4区 医学
Open Forum Infectious Diseases Pub Date : 2024-10-16 eCollection Date: 2024-11-01 DOI: 10.1093/ofid/ofae626
Jacob D Sherman, Vinit Karmali, Bhoj Kumar, Trevor W Simon, Sarah Bechnak, Anusha Panjwani, Caroline R Ciric, Dongli Wang, Christopher Huerta, Brandi Johnson, Evan J Anderson, Nadine Rouphael, Matthew H Collins, Christina A Rostad, Parastoo Azadi, Erin M Scherer
{"title":"Altered Spike Immunoglobulin G Fc N-Linked Glycans Are Associated With Hyperinflammatory State in Adult Coronavirus Disease 2019 and Multisystem Inflammatory Syndrome in Children.","authors":"Jacob D Sherman, Vinit Karmali, Bhoj Kumar, Trevor W Simon, Sarah Bechnak, Anusha Panjwani, Caroline R Ciric, Dongli Wang, Christopher Huerta, Brandi Johnson, Evan J Anderson, Nadine Rouphael, Matthew H Collins, Christina A Rostad, Parastoo Azadi, Erin M Scherer","doi":"10.1093/ofid/ofae626","DOIUrl":"10.1093/ofid/ofae626","url":null,"abstract":"<p><strong>Background: </strong>Severe coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome (MIS-C) are characterized by excessive inflammatory cytokines/chemokines. In adults, disease severity is associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific immunoglobulin G (IgG) Fc afucosylation, which induces proinflammatory cytokine secretion from innate immune cells. This study aimed to define spike IgG Fc glycosylation following SARS-CoV-2 infection in adults and children and following SARS-CoV-2 vaccination in adults and the relationships between glycan modifications and cytokines/chemokines.</p><p><strong>Methods: </strong>We analyzed longitudinal (n = 146) and cross-sectional (n = 49) serum/plasma samples from adult and pediatric COVID-19 patients, MIS-C patients, adult vaccinees, and adult and pediatric controls. We developed methods for characterizing bulk and spike IgG Fc glycosylation by capillary electrophoresis and measured levels of 10 inflammatory cytokines/chemokines by multiplexed enzyme-linked immunosorbent assay.</p><p><strong>Results: </strong>Spike IgG was more afucosylated than bulk IgG during acute adult COVID-19 and MIS-C. We observed an opposite trend following vaccination, but it was not significant. Spike IgG was more galactosylated and sialylated and less bisected than bulk IgG during adult COVID-19, with similar trends observed during pediatric COVID-19/MIS-C and following SARS-CoV-2 vaccination. Spike IgG glycosylation changed with time following adult COVID-19 or vaccination. Afucosylated spike IgG exhibited inverse and positive correlations with inflammatory markers in MIS-C and following vaccination, respectively; galactosylated and sialylated spike IgG inversely correlated with proinflammatory cytokines in adult COVID-19 and MIS-C; and bisected spike IgG positively correlated with inflammatory cytokines/chemokines in multiple groups.</p><p><strong>Conclusions: </strong>We identified previously undescribed relationships between spike IgG glycan modifications and inflammatory cytokines/chemokines that expand our understanding of IgG glycosylation changes that may impact COVID-19 and MIS-C immunopathology.</p>","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":"11 11","pages":"ofae626"},"PeriodicalIF":3.8,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11528514/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142566362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: Has Ghana's Rotavirus Vaccine Switch Met Programmatic Expectations? An Analysis of National Surveillance Data; 2018-2022. 更正:加纳轮状病毒疫苗转换达到计划预期了吗?2018-2022年全国监测数据分析》。
IF 3.8 4区 医学
Open Forum Infectious Diseases Pub Date : 2024-10-16 eCollection Date: 2024-10-01 DOI: 10.1093/ofid/ofae624
{"title":"Correction to: Has Ghana's Rotavirus Vaccine Switch Met Programmatic Expectations? An Analysis of National Surveillance Data; 2018-2022.","authors":"","doi":"10.1093/ofid/ofae624","DOIUrl":"https://doi.org/10.1093/ofid/ofae624","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1093/ofid/ofae539.].</p>","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":"11 10","pages":"ofae624"},"PeriodicalIF":3.8,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11482000/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142471531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Review of Evidence Related to the Zoonotic Characteristics of the Monkeypox Virus. 猴痘病毒人畜共患病特征相关证据综述。
IF 3.8 4区 医学
Open Forum Infectious Diseases Pub Date : 2024-10-15 eCollection Date: 2024-10-01 DOI: 10.1093/ofid/ofae503
Kawsari Abdullah, Junayd Hussain, Emilie Chan, Kylie Tingley, Valentina Ly, J Scott Weese, Nicole Shaver, Alexandria Bennett, Melissa Brouwers
{"title":"A Review of Evidence Related to the Zoonotic Characteristics of the Monkeypox Virus.","authors":"Kawsari Abdullah, Junayd Hussain, Emilie Chan, Kylie Tingley, Valentina Ly, J Scott Weese, Nicole Shaver, Alexandria Bennett, Melissa Brouwers","doi":"10.1093/ofid/ofae503","DOIUrl":"https://doi.org/10.1093/ofid/ofae503","url":null,"abstract":"<p><p>The 2022 monkeypox virus (MPXV) outbreaks spurred global public health concern. In response, we undertook a living systematic review of its zoonotic characteristics, including potential reservoirs and susceptible species, transmissibility, and clinical presentation in nonhuman species. Electronic database searches yielded 148 eligible records published between 2000 and 2022. Primary reservoirs remain unidentified, with natural isolation identified in 2 species, the sooty mangabey monkey and rope squirrel. Transmission primarily occurs from animals to humans, but evidence of reverse zoonosis has emerged. Data on clinical infection and manifestations are sparse, with evidence of potentially susceptible species drawn primarily from experimental studies. Only 10% of articles were appropriate for quality assessment and most of these were rated as critically low. Overall, while evidence regarding MPXV exists, the quality of data are extremely poor, resulting in significant uncertainty regarding MPXV's zoonotic traits. High-quality empirical research to understand the impact of MPXV on animal and human populations is warranted.</p>","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":"11 Suppl 2","pages":"S146-S155"},"PeriodicalIF":3.8,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476936/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142471593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk of Reinfection and Incidence of Chronic Symptoms After SARS-CoV-2 Infections. 感染 SARS-CoV-2 后再感染的风险和慢性症状的发生率。
IF 3.8 4区 医学
Open Forum Infectious Diseases Pub Date : 2024-10-15 eCollection Date: 2024-10-01 DOI: 10.1093/ofid/ofae608
Liam Golding, Allison W Watts, Mark Pitblado, Felicity Clemens, Marina Viñeta Paramo, Jacob Shew, Michael A Irvine, Bahaa Abu-Raya, David M Goldfarb, Louise C Mâsse, Pascal M Lavoie
{"title":"Risk of Reinfection and Incidence of Chronic Symptoms After SARS-CoV-2 Infections.","authors":"Liam Golding, Allison W Watts, Mark Pitblado, Felicity Clemens, Marina Viñeta Paramo, Jacob Shew, Michael A Irvine, Bahaa Abu-Raya, David M Goldfarb, Louise C Mâsse, Pascal M Lavoie","doi":"10.1093/ofid/ofae608","DOIUrl":"https://doi.org/10.1093/ofid/ofae608","url":null,"abstract":"<p><p>This study showed that a severe acute respiratory syndrome coronavirus 2 infection reduced the risk of reinfection among vaccinated individuals by 0.50 (95% CI, 0.39-0.64) over a 1-year period, after accounting for unreported infections using avidity-based serology. Reciprocally, chronic symptoms increased from a baseline of 21% (95% CI, 16%-28%) among infection-naïve individuals to 43% (95% CI, 30%-61%) in reinfected individuals.</p>","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":"11 10","pages":"ofae608"},"PeriodicalIF":3.8,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11521332/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142546622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Community Mobilization to Guide the Public Health Response During the 2022 Ontario Mpox Outbreak: A Brief Report. 2022 年安大略省麻疹疫情爆发期间指导公共卫生响应的社区动员:简要报告。
IF 3.8 4区 医学
Open Forum Infectious Diseases Pub Date : 2024-10-15 eCollection Date: 2024-10-01 DOI: 10.1093/ofid/ofae195
Darrell H S Tan, Adam Awad, Austin Zygmunt, James Murray, Daniel Warshafsky, Sharmistha Mishra, Dane Griffiths
{"title":"Community Mobilization to Guide the Public Health Response During the 2022 Ontario Mpox Outbreak: A Brief Report.","authors":"Darrell H S Tan, Adam Awad, Austin Zygmunt, James Murray, Daniel Warshafsky, Sharmistha Mishra, Dane Griffiths","doi":"10.1093/ofid/ofae195","DOIUrl":"https://doi.org/10.1093/ofid/ofae195","url":null,"abstract":"<p><p>The 2022 mpox epidemic predominantly affected gay, bisexual, and other men who have sex with men (GBM). Led by a provincial community program and co-galvanized by clinician-researchers, GBM community leaders in Ontario coordinated a robust response, representing a reproducible strategy for community engagement and mobilization during future epidemics.</p>","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":"11 Suppl 2","pages":"S129-S132"},"PeriodicalIF":3.8,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476808/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142471594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Virus Load Kinetics in Lassa Fever Patients Treated With Ribavirin: A Retrospective Cohort Study From Southern Nigeria. 接受利巴韦林治疗的拉沙热患者的病毒载量动力学:尼日利亚南部的一项回顾性队列研究。
IF 3.8 4区 医学
Open Forum Infectious Diseases Pub Date : 2024-10-15 eCollection Date: 2024-10-01 DOI: 10.1093/ofid/ofae575
Ephraim Ogbaini-Emovon, George Akpede, Sylvanus Okogbenin, Emmanuel Osagiede, Ekaete Tobin, Danny Asogun, Peter Okokhere, Martha Okonofua, Nosa Akpede, Peter Akhideno, Cyril Erameh, Mojeed Rafiu, Chukwuemeka Azubuike, Kelly Iraoya, Chris Iruolagbe, Christian Erohubie, Dazumi Ahmed, Osahogie Ediawe, Joseph Okoguale, Reuben Eifediyi, Ikponmwonsa Odia, Jacqueline Agbukor, Donatus Adomeh, Maxy A C Odike, Wilson Ovienria, Anieno Elkanem, Ekene B Muoebenam, Kingsley C Ojide, Elisa Pallasch, Jonas Müller, Julia Hinzmann, Stephan Günther, Meike Pahlmann, Anke Thielebein, Sophie Duraffour, Lisa Oestereich, Ralf Krumkamp
{"title":"Virus Load Kinetics in Lassa Fever Patients Treated With Ribavirin: A Retrospective Cohort Study From Southern Nigeria.","authors":"Ephraim Ogbaini-Emovon, George Akpede, Sylvanus Okogbenin, Emmanuel Osagiede, Ekaete Tobin, Danny Asogun, Peter Okokhere, Martha Okonofua, Nosa Akpede, Peter Akhideno, Cyril Erameh, Mojeed Rafiu, Chukwuemeka Azubuike, Kelly Iraoya, Chris Iruolagbe, Christian Erohubie, Dazumi Ahmed, Osahogie Ediawe, Joseph Okoguale, Reuben Eifediyi, Ikponmwonsa Odia, Jacqueline Agbukor, Donatus Adomeh, Maxy A C Odike, Wilson Ovienria, Anieno Elkanem, Ekene B Muoebenam, Kingsley C Ojide, Elisa Pallasch, Jonas Müller, Julia Hinzmann, Stephan Günther, Meike Pahlmann, Anke Thielebein, Sophie Duraffour, Lisa Oestereich, Ralf Krumkamp","doi":"10.1093/ofid/ofae575","DOIUrl":"https://doi.org/10.1093/ofid/ofae575","url":null,"abstract":"<p><strong>Background: </strong>The standard of care for Lassa fever is the use of ribavirin with supportive therapy. There is little information on the course of viremia and its relationship with clinical outcomes in patients treated with ribavirin.</p><p><strong>Methods: </strong>We conducted a retrospective analysis of virologic and clinical parameters of 152 reverse transcription polymerase chain reaction-confirmed Lassa fever cases admitted and treated with ribavirin therapy. We describe the Lassa virus RNA kinetics in blood in relation to the clinical course of the patients.</p><p><strong>Results: </strong>The overall mortality was 9%. The median duration (interquartile range [IQR]) of illness before admission was 8 (5-12) days. Median (IQR) Ct values on admission (<i>t<sub>0</sub></i> ) were lower among patients who died (21 [20-27]) than in those who survived (34 [30-37]; <i>P</i> < .01). The receiver operating characteristics curve of the association between outcome and Ct value at <i>t<sub>0</sub></i> had a high classification performance, with an AUC of 0.92 (95% CI, 0.86-0.98). The median time to viral clearance (IQR) was 10 (5-15) days. The viral load decreased steadily with the duration of treatment, and all survivors achieved viral clearance within 25 days of hospitalization.</p><p><strong>Conclusions: </strong>Our study demonstrates that the Ct value on admission has prognostic value and Lassa fever patients treated with ribavirin typically clear the virus within 3-4 weeks of hospitalization. This kinetics has implications for the design of clinical case management and future clinical trial protocols.</p>","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":"11 10","pages":"ofae575"},"PeriodicalIF":3.8,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11500659/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142505245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ideal Time to Conduct a Pharmacokinetic Investigation After Delivery to Fully Capture the Effect of Pregnancy on Drug Exposure. 产后进行药代动力学调查的理想时间,以充分捕捉妊娠对药物暴露的影响。
IF 3.8 4区 医学
Open Forum Infectious Diseases Pub Date : 2024-10-15 eCollection Date: 2024-10-01 DOI: 10.1093/ofid/ofae585
Mattia Berton, Felix Stader, Sara Bettonte, Manuel Battegay, Catia Marzolini
{"title":"Ideal Time to Conduct a Pharmacokinetic Investigation After Delivery to Fully Capture the Effect of Pregnancy on Drug Exposure.","authors":"Mattia Berton, Felix Stader, Sara Bettonte, Manuel Battegay, Catia Marzolini","doi":"10.1093/ofid/ofae585","DOIUrl":"https://doi.org/10.1093/ofid/ofae585","url":null,"abstract":"<p><strong>Background: </strong>The World Health Organization is pushing to accelerate the study of new human immunodeficiency virus drugs in pregnant women. However, regulatory guidelines do not specify when to conduct pharmacokinetic studies in postpartum women. This knowledge gap carries the potential to jeopardize the outcomes and conclusions of clinical trials aiming to study the effect of pregnancy on drug exposure. We used physiologically based pharmacokinetic (PBPK) modeling along with clinical data to determine the time needed after delivery for drug exposure to return to prepregnancy levels.</p><p><strong>Methods: </strong>A literature review was conducted to collect physiological parameters of pregnant and postpartum women. Regression analyses were performed to derive equations describing the parameters trajectory throughout pregnancy and post partum to inform our PBPK model. Published pharmacokinetic data in pregnant and postpartum women were used for the model verification. The PBPK model was subsequently applied to investigate pharmacokinetic changes throughout pregnancy and post partum.</p><p><strong>Results: </strong>In agreement with the clinical data the PBPK model was able to describe the different effects of pregnancy on drug exposure, with bictegravir showing the largest reduction in exposure (approximately 50%) during the third trimester while ritonavir and raltegravir showing the lowest (approximately 30%). The successfully verified PBPK model predicted that all evaluated antiretrovirals mostly return to prepregnancy exposure 4 weeks after delivery.</p><p><strong>Conclusions: </strong>Pharmacokinetic investigations on hepatically cleared drugs should not be conducted before the fifth week after delivery to fully characterize the effect of pregnancy on drug exposure. Because physiological changes remain after delivery, early measurements can underestimate the pregnancy effect on pharmacokinetics, leading to suboptimal dosing recommendations during pregnancy.</p>","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":"11 10","pages":"ofae585"},"PeriodicalIF":3.8,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495486/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142505242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral Vancomycin to Prevent Clostridioides difficile in Stem Cell Transplant Recipients: The Last Frontier in Antimicrobial Prophylaxis. 口服万古霉素预防干细胞移植受者感染艰难梭菌:抗菌预防的最后前沿。
IF 3.8 4区 医学
Open Forum Infectious Diseases Pub Date : 2024-10-14 eCollection Date: 2024-11-01 DOI: 10.1093/ofid/ofae623
Carolyn D Alonso
{"title":"Oral Vancomycin to Prevent <i>Clostridioides difficile</i> in Stem Cell Transplant Recipients: The Last Frontier in Antimicrobial Prophylaxis.","authors":"Carolyn D Alonso","doi":"10.1093/ofid/ofae623","DOIUrl":"10.1093/ofid/ofae623","url":null,"abstract":"","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":"11 11","pages":"ofae623"},"PeriodicalIF":3.8,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11532820/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142576725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immune Reconstitution Inflammatory Syndrome in a Patient With Cutaneous Leishmaniasis and HIV: A Diagnostic Challenge for Clinicians Caring for a Migrant Population in the United States. 皮肤利什曼病和艾滋病患者的免疫重建炎症综合征:为美国移民提供护理的临床医生面临的诊断挑战。
IF 3.8 4区 医学
Open Forum Infectious Diseases Pub Date : 2024-10-14 eCollection Date: 2024-10-01 DOI: 10.1093/ofid/ofae587
Alejandro De La Hoz, Nirupa Gadi, Christina G Lopez, Alejandro Barrera-Godinez, Nancy S Miller, Daniel L Bourque, Candice Brem, Ekin Ozluk, Geetika Seth, Sarah Kimball, Jessica L Taylor
{"title":"Immune Reconstitution Inflammatory Syndrome in a Patient With Cutaneous Leishmaniasis and HIV: A Diagnostic Challenge for Clinicians Caring for a Migrant Population in the United States.","authors":"Alejandro De La Hoz, Nirupa Gadi, Christina G Lopez, Alejandro Barrera-Godinez, Nancy S Miller, Daniel L Bourque, Candice Brem, Ekin Ozluk, Geetika Seth, Sarah Kimball, Jessica L Taylor","doi":"10.1093/ofid/ofae587","DOIUrl":"https://doi.org/10.1093/ofid/ofae587","url":null,"abstract":"<p><p>Migration routes determine exposure to endemic infections. We present a case of complex cutaneous leishmaniasis in a man with HIV infection who migrated to the United States from Haiti, where <i>Leishmania</i> is uncommon, acquiring leishmaniasis while on his journey via South America and Central America. His presentation included hyperpigmented, nonulcerated plaques and nodules on his extremities, chest, back, face, palms, and soles; initially he had no mucosal lesions. Infection with <i>Leishmania panamensis</i> was confirmed via polymerase chain reaction. He was prescribed bictegravir/tenofovir alafenamide/emtricitabine with rapid suppression of HIV and liposomal amphotericin B for diffuse cutaneous leishmaniasis with a limited initial response. He subsequently developed mucosal lesions in the setting of immune reconstitution and was retreated with amphotericin dosed for mucocutaneous disease. A thorough migration history was critical to diagnosis. This case highlights the different presentations of leishmaniasis in people with HIV and the elevated risk for treatment failure.</p>","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":"11 10","pages":"ofae587"},"PeriodicalIF":3.8,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11518855/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142546616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信